Sensei Biotherapeutics doses patients in tumour therapy trial
US-based biotechnology company Sensei Biotherapeutics has dosed the first patient in a Phase I/II clinical trial of SNS-101 to treat …
Clearside opens enrolment in Phase IIb trial of wet AMD therapy
US-based biopharmaceutical company Clearside Biomedical has begun enrolling patients in its Phase IIb trial of CLS-AX (axitinib injectable suspension). The multi-centre …
Hookipa debuts Phase I/II data
Hookipa Pharma has reported preliminary positive data and trial updates from its ongoing phase II study of HB-200 in combination …
NeuroMetrix encouraged by Phase II Quell data
NeuroMetrix is gearing up to present partial trial results on Quell, the company’s wireless transcutaneous electric nerve stimulation (TENS) device, …
Adiso completes Phase Ib MAD study of UC therapy
Adiso Therapeutics has completed a Phase Ib multiple ascending dose (MAD) trial of ADS051 (BT051) for the treatment of moderate-to-severe …
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Nacuity achieves target enrolment in RP therapy trial
Nacuity Pharmaceuticals has achieved its target enrolment of 48 patients in the SLO-RP Phase I/II clinical trial of NPI-001 tablets …
China dominates CAR-T therapies
Chimeric antigen receptor (CAR)-T cell therapy is an innovative approach within cancer treatment. By genetically modifying a patient’s own immune …
FDA grants clearance to Minoryx for Phase III trial of cALD therapy
The US Food and Drug Administration (FDA) has granted clearance to Minoryx Therapeutics to initiate a Phase III clinical trial …
Cocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
Cocrystal Pharma has received approval from the Australian Human Research Ethics Committee (HREC) to initiate a Phase I trial of …
Nykode collaborates with Roche for an upcoming trial in cervical cancer
Nykode Therapeutics has teamed up with Roche to collaborate in an upcoming clinical trial in advanced cervical cancer. The trial …
FDA clears IGM Biosciences’ INDs for SLE and RA therapy trials
The US Food and Drug Administration (FDA) has cleared IGM Biosciences’ two investigational new drug (IND) applications for initiating Phase …
Jnana reports topline data from Phase Ia trial of PKU therapy
Jnana Therapeutics has reported positive topline data from the Phase Ia clinical trial of JNT-517, a potential first-in-class oral treatment …
Pfizer’s haemophilia drug succeeds in Phase III trial
Pfizer’s once-a-week antibody treatment for haemophilia A and B helped reduce bleeding events in patients compared to their usual treatment, …
Positive Phase I results for Prader-Willi Syndrome drug
ConSynance Therapeutics on Tuesday has reported positive results from its Phase I trial of CSTI-500, a first-in-class drug for the …
selectION reports safety results from SAD stage of si-544 Phase Ib trial
selectION has reported initial safety results from the single ascending dose (SAD) stage of its ongoing Phase Ib trial of …